ZYPREXA INTRAMUSCULAR
Drug timelines are a Plus or Pro feature.
21 regulatory and trial events tracked for ZYPREXA INTRAMUSCULAR, covering 2006-08-25 to 2026-01-30. Get the full timeline:
Most recent: FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)